DOCSLIB.ORG

Psychological Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Psychological Medicine King’s Health Partners | Behavioural and Developmental Psychiatry: Clinical Academic Group Outcomes Psychological Medicine Clinical Academic Group King’s Health Partners n King’s Health Partners brings together: n three of the UKs leading NHS Foundation Trusts n a university ranked 8th in the world for clinical, pre-clinical and health n 4.2m patient contacts each year n over 36,000 staff n more than 25,000 students n a combined annual turnover of £3.1bn n services provided across central and south London and beyond, including nine mental health and physical healthcare hospitals and many community sites n a comprehensive portfolio of high quality clinical services with international recognition in cancer, diabetes, mental health, regenerative medicine, transplantation, cardiac and clinical neurosciences n a major trauma centre and two hyper-acute stroke units King’s Health Partners | Psychological Medicine Clinical Academic Group About King’s Health Partners King’s Health Partners Academic Health Sciences n increase the value of the care we provide and Centre brings together one of the world’s top the outcomes we achieve for our patients and research-led universities, King’s College London, service users and three of London’s most prestigious and highly regarded NHS Foundation Trusts – Guy’s and n integrate care across local primary, St Thomas’, King’s College Hospital and South secondary and social care services to make it London and Maudsley. easier for people to get the care and support they need Our partnership provides a powerful combination of complex clinical specialties that cover a wide n improve the public health of our local range of physical and mental health conditions community by tackling inequalities and and a breadth of research expertise that spans supporting people to live healthy lives disciplines from medicine and biomedical sciences to the social sciences and humanities. n bring together our collective strength and expertise in a range of specialist There are three parts to our mission: excellence areas to deliver world-leading care, in research, education and clinical care. research and education To support our mission, we are delivering We are uniquely structured to deliver our mission programmes of work to: for excellence. Our 21 Clinical Academic Groups (CAGs) bring together all the clinical services n join up mental and physical healthcare so that and staff from the three trusts with the relevant we treat the whole person, mind and body academic departments of King’s College London. 01 King’s Health Partners | Psychological Medicine Clinical Academic Group Foreword At King’s Health Partners we are committed to The primary purpose of King’s Health Partners is to improving outcomes for our patients and service improve health and wellbeing locally and globally. users and achieving maximum value for money We must deliver this goal in a challenging economic in everything we do. We believe that being open environment with rising demand for, and costs and transparent about the care and outcomes we of, healthcare. We will only achieve sustainable deliver results in a culture of improvement across health improvement if we strive always to increase our partnership. value. We define value in terms of outcomes that matter to patients, over the full cycle of care, This is why we are publishing a series of outcomes divided by the cost of producing those outcomes. books that will help patients, service users, carers, By publishing outcomes books we have more referring clinicians and commissioners to make better information to support us measuring the value informed decisions, and our staff to drive up the of the healthcare we provide. quality of the care we provide. The books report key outcomes for treatments provided by our 21 Clinical Our goal is to increase the depth and breadth of Academic Groups (CAGs). CAGs form the building reporting each year. Books will be updated regularly blocks of our Academic Health Sciences Centre. By to demonstrate progress against our mission to bringing together our clinical and academic staff achieve world-class research, education and clinical across teaching, training and research, we can use care. We hope you find these data valuable. their combined expertise to achieve better outcomes Please send comments and suggestions to us for our patients and service users. at [email protected] Our books are designed for a clinical and lay For more information please visit our website audience and contain a summary of patient at www.kingshealthpartners.org volumes and measures (e.g. length of stay, re- Professor John Moxham, Director of Clinical admissions, patient experience), clinical outcomes, educational activities, technological and research Strategy, King’s Health Partners innovations and publications. They also focus March 2017 on other important measures, such as staff satisfaction and wellbeing. 02 King’s Health Partners | Psychological Medicine Clinical Academic Group Foreword from CAG Leadership The Psychological Medicine CAG is central to the The CAG structure changed in July 2016 to form King’s Health Partners mission in having a major the new Psychological Medicine and Integrated focus on delivering research and clinical care across Care CAG. This was the result of a merger of mental and physical health. The CAG comprises the Mood, Anxiety and Personality CAG and of academic and clinical staff working within the Liaison and Specialist services of the old King’s College London, clinical services within Psychological Medicine CAG. We hope the book the secondary care setting providing front end gives an overview of our clinical services, research crisis function and tertiary specialist services with highlights and the strategic vision of our CAG a focus on physical/psychological interface of the within King’s Health Partners and will provide South London & Maudsley NHS Foundation Trust. a foundation for the future measurement of This book highlights the clinical outcomes of the the progress and delivery of the Psychological diverse range of services across the CAG and more Medicine and Integrated Care CAG. importantly the service user experiences based on information obtained from 2013 to 2015. Ranga Rao, Clinical Director Apart from providing high quality of services, Matthew Hotopf, Academic Director demonstrating clinical outcomes that are meaningful for service users and clinicians and Steve Davidson, Service Director that can be measured as part of the routine clinical activity forms an integral part of our governance strategy. 03 King’s Health Partners | Psychological Medicine Clinical Academic Group Contents The value of partnership at King’s Health Partners 05 Introduction 08 CAG leadership 10 Our vision and strategy 11 Our services 13 Introduction to service user and carer engagement and experience 19 Introduction to clinical outcome measures 22 CASCAID service 25 Psychosexual service 34 Eating disorders care pathway 42 Mother and baby/Perinatal services 55 Chronic fatigue service 68 Quality and safety measures across the Complex Care Pathway 79 Mental health liaison 82 Triage services 84 Home treatment teams 92 Quality and safety measure for crisis care pathway 100 Neuropsychiatry 104 Research in focus 109 Neuro-radiology 111 MRI 112 Research in focus for neuropsychiatry 113 Staff satisfaction 118 Education and training 121 Academic research and innovations 128 04 King’s Health Partners | Psychological Medicine Clinical Academic Group The value of partnership at King’s Health Partners The mind and body are inseparable, and mental mental ill health improves physical health outcomes and physical health conditions are often connected. and vice versa. The average life expectancy for someone with Right across our partnership, we are committed a long-term mental health illness is much shorter to joining up and delivering excellent mental and than for someone without, often due in part to physical healthcare, research and education so smoking, obesity, diabetes or alcohol misuse. that we treat the whole person, by: Likewise, many people with long-term physical health conditions suffer from depression or n screening all patients with chronic physical other mental health conditions. diseases for mental health conditions, and using the learning from this to improve the Despite this, health services separate care into care we provide physical and mental and often fail to share patient information. n improving our understanding of the physical health needs of people with severe mental At King’s Health Partners we are working to ill health overcome these barriers by treating the whole person. We are committed to caring for vulnerable n addressing the traditional distinctions between patients with both physical and mental ill health in the mind and body in research and education an integrated manner with better, faster diagnosis allowing us to train students and staff to and treatment because we know that addressing deliver more integrated care 05 King’s Health Partners | Psychological Medicine Clinical Academic Group n better organising and expanding current Alcohol strategy – key aims training provision for physical and psychiatric comorbidity n developing appropriate resources for clinical staff and patients n working with our local commissioners to find new ways of paying for integrated services n developing and implementing training for all staff on harmful drinking supporting early n linking IT systems across our partner trusts identification and intervention
Load more

Recommended publications
  • Neuropsychiatry: Towards a Philosophy of Praxis
    rev colomb psiquiat. 2017;46(S1):28–35 www.elsevier.es/rcp Artículo de revisión Neuropsychiatry: Towards a Philosophy of Praxis Jesús Ramirez-Bermudez a,b,∗, Rodrigo Perez-Esparza b, Luis Carlos Aguilar-Venegas b, Perminder Sachdev c,d a Department of Neuropsychiatry, National Institute of Neurology and Neurosurgery, Mexico City, México b Medical School of the National University of Mexico, Mexico City, México c Neuropsychiatric Institute, The Prince of Wales Hospital, Sydney, Australia d Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia article info abstract Article history: Neuropsychiatry is a specialized clinical, academic and scientific discipline with its field Received 22 June 2017 located in the borderland territory between neurology and psychiatry. In this article, we Accepted 10 July 2017 approach the theoretical definition of neuropsychiatry, and in order to address the practi- Available online 18 August 2017 cal aspects of the discipline, we describe the profile of a neuropsychiatric liaison service in the setting of a large hospital for neurological diseases in a middle-income country. Keywords: An audit of consecutive in-patients requiring neuropsychiatric assessment at the National Neurology Institute of Neurology and Neurosurgery of Mexico is reported, comprising a total of 1212 Psychiatry patients. The main neurological diagnoses were brain infections (21%), brain neoplasms Neuropsychiatry (17%), cerebrovascular disease (14%), epilepsy (8%), white matter diseases (5%), peripheral Behavioral neurology neuropathies (5%), extrapyramidal diseases (4%), ataxia (2%), and traumatic brain injury and related phenomena (1.8%). The most frequent neuropsychiatric diagnoses were delirium (36%), depressive disorders (16.4%), dementia (14%), anxiety disorders (8%), frontal syn- dromes (5%), adjustment disorders (4%), psychosis (3%), somatoform disorders (3%), and catatonia (3%).
    [Show full text]
  • Mapother House & Michael Rutter Centre, Maudsley Hospital
    Mapother House & Michael Rutter Centre, Maudsley Hospital (Reference: 20/AP/2768) This document provides an overview of the South London and Maudsley NHS Trust’s (SLaM) application for the redevelopment of Mapother House, Michael Rutter Centre and the Professorial Building. The application seeks to deliver new homes and enable the transformation of our inpatient facilities to create buildings fit to deliver world class mental health care in the 21st century - modernised, high quality, inpatient and community facilities serving communities in Southwark and Lambeth, as well as a centre for national excellence. Background South London and Maudsley NHS Foundation Trust SLaM provides the widest range of NHS mental health services in the UK. We aim to make a difference to lives by seeking excellence in all areas of mental health and wellbeing. Our 4,800 staff serve a local population of 1.3 million people. We offer more than 230 services including inpatient wards, outpatient and community services. We provide inpatient care for approximately 3,900 people each year and we treat more than 67,000 patients in Lambeth, Southwark, Lewisham and Croydon. We also provide more than 50 specialist services for children and adults across the UK including perinatal services, eating disorders, psychosis and autism. Masterplan South London and Maudsley NHS Foundation Trust (SLaM) and its partners are investing £140 million in modern mental healthcare services and facilities at our Maudsley Hospital site, providing better care and experience for local people. The upgrades to the site have formed a Masterplan, which includes three initial phases (1A-C): • 1A: Transforming Douglas Bennett House into a modern inpatient facility with eight co-designed adult wards.
    [Show full text]
  • Low-Intensity Transcranial Current Stimulation in Psychiatry
    REVIEWS AND OVERVIEWS Evidence-Based Psychiatric Treatment Low-Intensity Transcranial Current Stimulation in Psychiatry Noah S. Philip, M.D., Brent G. Nelson, M.D., Flavio Frohlich, Ph.D., Kelvin O. Lim, M.D., Alik S. Widge, M.D., Ph.D., Linda L. Carpenter, M.D. Neurostimulation is rapidly emerging as an important treat- schizophrenia, cognitive disorders, and substance use dis- ment modality for psychiatric disorders. One of the fastest- orders. The relative ease of use and abundant access to tCS growing and least-regulated approaches to noninvasive may represent a broad-reaching and important advance for therapeutic stimulation involves the application of weak future mental health care. Evidence supports application of electrical currents. Widespread enthusiasm for low-intensity one type of tCS, transcranial direct current stimulation (tDCS), transcranial electrical current stimulation (tCS) is reflected for major depression. However, tDCS devices do not have by the recent surge in direct-to-consumer device marketing, regulatory approval for treating medical disorders, evidence do-it-yourself enthusiasm, and an escalating number of is largely inconclusive for other therapeutic areas, and their use clinical trials. In the wake of this rapid growth, clinicians may is associated with some physical and psychiatric risks. One lack sufficient information about tCS to inform their clinical unexpected finding to arise from this review is that the use practices. Interpretation of tCS clinical trial data is aided by of cranial electrotherapy stimulation devices—the only cate- familiarity with basic neurophysiological principles, potential gory of tCS devices cleared for use in psychiatric disorders— mechanisms of action of tCS, and the complicated regulatory is supported by low-quality evidence.
    [Show full text]
  • Vascular Factors and Risk for Neuropsychiatric Symptoms in Alzheimer’S Disease: the Cache County Study
    International Psychogeriatrics (2008), 20:3, 538–553 C 2008 International Psychogeriatric Association doi:10.1017/S1041610208006704 Printed in the United Kingdom Vascular factors and risk for neuropsychiatric symptoms in Alzheimer’s disease: the Cache County Study .............................................................................................................................................................................................................................................................................. Katherine A. Treiber,1 Constantine G. Lyketsos,2 Chris Corcoran,3 Martin Steinberg,2 Maria Norton,4 Robert C. Green,5 Peter Rabins,2 David M. Stein,1 Kathleen A. Welsh-Bohmer,6 John C. S. Breitner7 and JoAnn T. Tschanz1 1Department of Psychology, Utah State University, Logan, U.S.A. 2Department of Psychiatry, Johns Hopkins Bayview and School of Medicine, Johns Hopkins University, Baltimore, U.S.A. 3Department of Mathematics and Statistics, Utah State University, Logan, U.S.A. 4Department of Family and Human Development, Utah State University, Logan, U.S.A. 5Departments of Neurology and Medicine, Boston University School of Medicine, Boston, U.S.A. 6Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, U.S.A. 7VA Puget Sound Health Care System, and Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, U.S.A. ABSTRACT Objective: To examine, in an exploratory analysis, the association between vascular conditions and the occurrence
    [Show full text]
  • B I B L I O G R a P H Y
    BIBLIOGRAPHY Our research is so good even our competitors use it! As of January 2018 See annotated abstracts and the full text articles of most of these studies at www.alpha-stim.com/healthcare-professionals/research-and-reports Electromedical Products International, Inc. 2201 Garrett Morris Parkway • Mineral Wells, TX 76067 USA (800) FOR-PAIN in the USA • Tel: (940) 328-0788 • Fax: (940) 328-0888 © Copyright 2018 by Electromedical Products International, Inc., All Rights Reserved. Electromedical Products International, Inc. (EPI) is always looking for researchers and clinicians who are interested in conducting research. While EPI does not pay salaries for researchers, the company will loan Alpha-Stim devices set up for double-blind randomized clinical trials, as well as provide or arrange for help in designing protocols, informed consent forms, recruiting ads, answering questions from the IRB, providing references, arranging for the statistical analyses, etc. Those qualified and interested in doing research with Alpha-Stim technology should contact: Jeffrey A. Marksberry, MD, Vice President of Science and Education at [email protected], or call (817) 458-3295. Randomized Controlled Trials 1. Hill N. The effects of alpha stimulation on induced anxiety. Digital Commons @ ACU, Electronic Theses and Dissertations. 2015; Paper 6. http://digitalcommons.acu.edu/etd/6 2. Lu L and Hu J. A Comparative study of anxiety disorders treatment with paroxetine in combination with cranial electrotherapy stimulation therapy. Medical Innovation of China. 2014; 11(08): 080-082. 3. Lee IH, Seo EJ and Lim IS. Effects of aquatic exercise and CES treatment on the changes of cognitive function, BDNF, IGF-1, and VEGF of persons with intellectual disabilities.
    [Show full text]
  • Junior Clinical Fellow in Neurosciences GRADE
    JOB SPECIFICATION JOB TITLE: Junior Clinical Fellow in Neurosciences GRADE: Junior Clinical Fellow HOURS: 40 plus on call RESPONSIBLE TO: Clinical Lead ACCOUNTABLE TO: Clinical Director - Neurosciences TENURE: 6 months Background King’s College Hospital King’s College Hospital is one of the largest and busiest in London, with a well-established national and international reputation for clinical excellence, innovation and achievement. Our Trust is located on multiple sites serving the economically diverse boroughs of Southwark, Lambeth and Bromley and Bexley. As a major employer with over 10,500 staff we play an important part in helping reduce local, social and health inequalities. The Trust provides a broad range of secondary services, including specialist emergency medicine (e.g. trauma, cardiac and stroke). It works in close collaboration with other health providers in South East London, including CCGs to ensure the sustainability and excellence of services across the area. In recent years, there has been substantial investment in both the facilities and resources of the hospital, which has transformed the quality of care that it now delivers. It also provides a number of leading edge tertiary services, such as liver transplantation, neurosciences, haemato-oncology, foetal medicine, cardiology and cardiac surgery, on a regional and national basis. King’s College Hospital has an enviable track record in research and development and service innovation. In partnership with King’s College London the Trust has recently been awarded a National Research Centre in Patient Safety and Service Quality. It is also a partner in two National Institute for Health Research biomedical research centres. The first is a Comprehensive centre with King’s College London and Guy’s and St Thomas’ NHS Foundation Trust and the second is a Specialist centre with the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry.
    [Show full text]
  • The Clinical Neuropsychiatry of Stroke, Second Edition
    The Clinical Neuropsychiatry of Stroke This fully revised new edition covers the range of neuropsychiatric syndromes associated with stroke, including cognitive, emotional, and behavioral disorders such as depression, anxiety, and psychosis. Since the last edition there has been an explosion of published literature on this topic and the book provides a comprehensive, systematic, and cohesive review of this new material. There is growing recognition among a wide range of clinicians and allied healthcare staff that poststroke neuropsychiatric syndromes are both common and serious. Such complications can have a negative impact on recovery and even survival; however, there is now evidence suggesting that pre-emptive therapeutic intervention in high-risk patient groups can prevent the initial onset of the conditions. This opportunity for primary prevention marks a huge advance in the man- agement of this patient population. This book should be read by all those involved in the care of stroke patients, including psychiatrists, neurologists, rehabilitation specialists, and nurses. Robert Robinson is a Paul W. Penningroth Professor and Head, Department of Psychiatry; Roy J. and Lucille A., Carver College of Medicine, The University of Iowa, IA, USA. The Clinical Neuropsychiatry of Stroke Second Edition Robert G. Robinson cambridge university press Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, São Paulo Cambridge University Press The Edinburgh Building, Cambridge cb2 2ru,UK Published in the United States of America by Cambridge University Press, New York www.cambridge.org Informationonthistitle:www.cambridge.org/9780521840071 © R. Robinson 2006 This publication is in copyright. Subject to statutory exception and to the provision of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of Cambridge University Press.
    [Show full text]
  • Behavioral Neurology Fellowship Core Curriculum
    AMERICAN ACADEMY OF NEUROLOGY BEHAVIORAL NEUROLOGY FELLOWSHIP CORE CURRICULUM 1. INTRODUCTION AND DEFINITIONS The specialty of Behavioral Neurology focuses on clinical and pathological aspects of neural processes associated with mental activity, subsuming cognitive functions, emotional states, and social behavior. Historically, the principal emphasis of Behavioral Neurology has been to characterize the phenomenology and pathophysiology of intellectual disturbances in relation to brain dysfunction, clinical diagnosis, and treatment. Representative cognitive domains of interest include attention, memory, language, high-order perceptual processing, skilled motor activities, and "frontal" or "executive" cognitive functions (adaptive problem-solving operations, abstract conceptualization, insight, planning, and sequencing, among others). Advances in cognitive neuroscience afforded by functional brain imaging techniques, electrophysiological methods, and experimental cognitive neuropsychology have nurtured the ongoing evolution and growth of Behavioral Neurology as a neurological subspecialty. Applying advances in basic neuroscience research, Behavioral Neurology is expanding our understanding of the neurobiological bases of cognition, emotions and social behavior. Although Behavioral Neurology and neuropsychiatry share some common areas of interest, the two fields differ in their scope and fundamental approaches, which reflect larger differences between neurology and psychiatry. Behavioral Neurology encompasses three general types of clinical
    [Show full text]
  • Clinically Useful Brain Imaging for Neuropsychiatry: How Can We Get There?
    bioRxiv preprint doi: https://doi.org/10.1101/115097; this version posted March 9, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Clinically Useful Brain Imaging for Neuropsychiatry: How Can We Get There? Michael P. Milham1,2, R. Cameron Craddock1,2 and Arno Klein1 1Center for the Developing Brain, Child Mind Institute, New York, NY 2Center for Biomedical Imaging and Neuromodulation, Nathan S. Kline Institute for Psychiatric Research, New York, NY Corresponding Author: Michael P. Milham, MD, PhD Phyllis Green and Randolph Cowen Scholar Child Mind Institute 445 Park Avenue New York, NY 10022 [email protected] bioRxiv preprint doi: https://doi.org/10.1101/115097; this version posted March 9, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Despite decades of research, visions of transforming neuropsychiatry through the development of brain imaging-based ‘growth charts’ or ‘lab tests’ have remained out of reach. In recent years, there is renewed enthusiasm about the prospect of achieving clinically useful tools capable of aiding the diagnosis and management of neuropsychiatric disorders. The present work explores the basis for this enthusiasm. We assert that there is no single advance that currently has the potential to drive the field of clinical brain imaging forward.
    [Show full text]
  • Abstract Introduction Eating Disorders: Definition Difficulties
    Clinical Neuropsychiatry (2017) 14, 5, 321-329 EYE MOVEMENT DESENSITIZATION AND REPROCESSING (EMDR) AND EATING DISORDERS: A SYSTEMATIC REVIEW Marina Balbo, Maria Zaccagnino, Martina Cussino, Cristina Civilotti Abstract Objective: Eating disorders (Eds) are considered an emergency from a medical, health and social point of view in all Western countries. Alongside the great attention paid to the subject in public and the social media, EDs are a source of perplexity both for the scientific community, which attempts to study the psychopathogenetic processes and maintenance mechanisms of EDs and to monitor clinical interventions, and for clinicians, who often find themselves with patients who are difficult to deal with, reluctant to change and set up a solid therapeutic alliance, and inclined to drop out. This article aims to study the use of the Eye Movement Desensitization and Reprocessing therapy (EMDR) in the treatment of EDs through a process of systematic revision of the literature, after defining EDs theoretically, underlining a possible traumatic origin for their onset. Method: In order to carry out a systematic analysis of the literature, the following bibliographic databases were used: EMBASE, MEDLINE, PsycINFO and CINAHL. The time criteria were set from the beginning of records to February 2017. Results: Despite noteworthy clinical suggestions, the scarcity thus far of the studies in the literature, and their methodological limitations, do not allow clear conclusions to be drawn with regard to EMDR’s efficacy. Conclusions: EMDR appears to be a promising approach, but further scientific evidence in support of its efficacy is required. Key words: Eating Disorders, Anorexia, Bulimia, Binge Eating Declaration of interest: no funding was provided for the conduct of the study and none of the authors have any conflicts of interest to declare; all persons who made substantial contributions to the work and meet the criteria for authorship have been included as authors for this paper.
    [Show full text]
  • Contents Editorial Commentaries Neuropsychiatry Movement
    Contents Volume 85 Issue 9 | JNNP September 2014 Editorial commentaries 982 Which target is best for patients with J Neurol Neurosurg Psychiatry: first published as on 1 September 2014. Downloaded from 947 Diagnosis on shaky grounds Parkinson’s disease? A meta-analysis of pallidal V S C Fung and subthalamic stimulation W Sako, Y Miyazaki, Y Izumi, R Kaji 949 Is the Pill Questionnaire useless? Your move, MDS Task Force 987 Tricks in dystonia: ordering the complexity Cover image: Mental Fitness, based on T van Eimeren V F M L Ramos, B I Karp, M Hallett the image by Richard Tuschman. Credit: Getty Images 950 Fetal grafting for Huntington’s disease. 994 Usefulness of frataxin immunoassays for the Is there a hope? diagnosis of Friedreich ataxia Editor E C Deutsch, D Oglesbee, N R Greeley, D R Lynch Matthew C Kiernan (Australia) J F Baizabal-Carvallo Deputy Editors Karen L Furie (USA) 951 Facial onset sensory motor neuronopathy Neurosurgery Michael Hanna (UK) (FOSMN) syndrome: an unusual amyotrophic 1003 Consensus on guidelines for stereotactic Associate Editors lateral sclerosis phenotype? neurosurgery for psychiatric disorders Alan Carson (UK) S Vucic OPEN ACCESS B Nuttin, H Wu, H Mayberg, M Hariz, Satoshi Kuwabara (Japan) L Gabriëls, T Galert, R Merkel, C Kubu, Nick Ward (UK) O Vilela-Filho, K Matthews, T Taira, A M Lozano, Peter Warnke (USA) 952 The classifi cation of neurological disorders in the 11th revision of the International G Schechtmann, P Doshi, G Broggi, J Régis, Web Editors A Alkhani, B Sun, S Eljamel, M Schulder, M Kaplitt,
    [Show full text]
  • Schizophrenia As a Self-Disorder Due to Perceptual Incoherence
    Schizophrenia Research 152 (2014) 41–50 Contents lists available at ScienceDirect Schizophrenia Research journal homepage: www.elsevier.com/locate/schres Review Schizophrenia as a self-disorderCORE due to perceptual incoherence Metadata, citation and similar papers at core.ac.uk L. Postmes a,⁎,H.N.Snob,S.Goedhartb,Provided J. van by derElsevier Stel - Publisherc,H.D.Heering Connector d,L.deHaand a GGZ Leiden, Department Early Psychosis (KEP) Leiden, Sandifortdreef 19, 2333 ZZ Leiden, the Netherlands b ZMC, Zaans Medical Centre, the Netherlands c GGZ Ingeest/VUmc, Amstelveen, the Netherlands d AMC, Academic Psychiatric Centre, Department Early Psychosis, Amsterdam, the Netherlands article info abstract Article history: The aim of this review is to describe the potential relationship between multisensory disintegration and self- Received 2 March 2013 disorders in schizophrenia spectrum disorders. Sensory processing impairments affecting multisensory integra- Received in revised form 9 July 2013 tion have been demonstrated in schizophrenia. From a developmental perspective multisensory integration is Accepted 11 July 2013 considered to be crucial for normal self-experience. An impairment of multisensory integration is called ‘percep- Available online 22 August 2013 tual incoherence’. We theorize that perceptual incoherence may evoke incoherent self-experiences including de- personalization, ambivalence, diminished sense of agency, and ‘loosening of associations’ between thoughts, Keywords: ‘ ’ Schizophrenia feelings and actions that lie within the framework of self-disorders as described by Sass and Parnas (2003). Self-disorders We postulate that subconscious attempts to restore perceptual coherence may induce hallucinations and delu- Perceptual incoherence sions. Increased insight into mechanisms underlying ‘self-disorders’ may enhance our understanding of schizo- Multisensory integration phrenia, improve recognition of early psychosis, and extend the range of therapeutic possibilities.
    [Show full text]